Cargando…
Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence
BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614057/ https://www.ncbi.nlm.nih.gov/pubmed/26516608 http://dx.doi.org/10.1002/brb3.373 |
_version_ | 1782396353891008512 |
---|---|
author | Siepmann, Timo Penzlin, Ana Isabel Kepplinger, Jessica Illigens, Ben Min‐Woo Weidner, Kerstin Reichmann, Heinz Barlinn, Kristian |
author_facet | Siepmann, Timo Penzlin, Ana Isabel Kepplinger, Jessica Illigens, Ben Min‐Woo Weidner, Kerstin Reichmann, Heinz Barlinn, Kristian |
author_sort | Siepmann, Timo |
collection | PubMed |
description | BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limited in these studies. The mechanisms of action whereby SSRI might improve recovery from acute ischemic stroke are not fully elucidated. METHODS: We searched MEDLINE using the PubMed interface to identify evidence of SSRI mediated improvement of recovery from acute ischemic stroke and reviewed the literature on the potential underlying mechanisms of action. RESULTS: Among identified clinical studies, a well‐designed randomized, double‐blind, and placebo‐controlled study (FLAME ‐ fluoxetine for motor recovery after acute ischemic stroke) demonstrated improved recovery of motor function in stroke patients receiving fluoxetine. The positive effects of SSRIs on stroke recovery were further supported by a meta‐analysis of 52 trials in a total of 4060 participants published by the Cochrane collaboration. Based on animal models, the mechanisms whereby SSRIs might ameliorate functional and structural ischemic‐brain damage were suggested to include stimulation of neurogenesis with migration of newly generated cells toward ischemic‐brain regions, anti‐inflammatory neuroprotection, improved regulation of cerebral blood flow, and modulation of the adrenergic neurohormonal system. However, to date, it remains speculative if and to what degree these mechanisms convert into humans and randomized controlled trials in large populations of stroke patients comparing different SSRIs are still lacking. CONCLUSION: In addition to the need of comprehensive‐clinical evidence, further elucidation of the beneficial mechanisms whereby SSRIs may improve structural and functional recovery from ischemic‐brain damage is needed to form a basis for translation into clinical practice. |
format | Online Article Text |
id | pubmed-4614057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46140572015-10-29 Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence Siepmann, Timo Penzlin, Ana Isabel Kepplinger, Jessica Illigens, Ben Min‐Woo Weidner, Kerstin Reichmann, Heinz Barlinn, Kristian Brain Behav Reviews BACKGROUND: Several clinical studies have indicated that selective serotonin reuptake inhibitors (SSRIs) administered in patients after acute ischemic stroke can improve clinical recovery independently of depression. Due to small sample sizes and heterogeneous study designs interpretability was limited in these studies. The mechanisms of action whereby SSRI might improve recovery from acute ischemic stroke are not fully elucidated. METHODS: We searched MEDLINE using the PubMed interface to identify evidence of SSRI mediated improvement of recovery from acute ischemic stroke and reviewed the literature on the potential underlying mechanisms of action. RESULTS: Among identified clinical studies, a well‐designed randomized, double‐blind, and placebo‐controlled study (FLAME ‐ fluoxetine for motor recovery after acute ischemic stroke) demonstrated improved recovery of motor function in stroke patients receiving fluoxetine. The positive effects of SSRIs on stroke recovery were further supported by a meta‐analysis of 52 trials in a total of 4060 participants published by the Cochrane collaboration. Based on animal models, the mechanisms whereby SSRIs might ameliorate functional and structural ischemic‐brain damage were suggested to include stimulation of neurogenesis with migration of newly generated cells toward ischemic‐brain regions, anti‐inflammatory neuroprotection, improved regulation of cerebral blood flow, and modulation of the adrenergic neurohormonal system. However, to date, it remains speculative if and to what degree these mechanisms convert into humans and randomized controlled trials in large populations of stroke patients comparing different SSRIs are still lacking. CONCLUSION: In addition to the need of comprehensive‐clinical evidence, further elucidation of the beneficial mechanisms whereby SSRIs may improve structural and functional recovery from ischemic‐brain damage is needed to form a basis for translation into clinical practice. John Wiley and Sons Inc. 2015-09-23 /pmc/articles/PMC4614057/ /pubmed/26516608 http://dx.doi.org/10.1002/brb3.373 Text en © 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Siepmann, Timo Penzlin, Ana Isabel Kepplinger, Jessica Illigens, Ben Min‐Woo Weidner, Kerstin Reichmann, Heinz Barlinn, Kristian Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title | Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title_full | Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title_fullStr | Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title_full_unstemmed | Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title_short | Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
title_sort | selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614057/ https://www.ncbi.nlm.nih.gov/pubmed/26516608 http://dx.doi.org/10.1002/brb3.373 |
work_keys_str_mv | AT siepmanntimo selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT penzlinanaisabel selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT kepplingerjessica selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT illigensbenminwoo selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT weidnerkerstin selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT reichmannheinz selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence AT barlinnkristian selectiveserotoninreuptakeinhibitorstoimproveoutcomeinacuteischemicstrokepossiblemechanismsandclinicalevidence |